MM

Mike McMullen

President and Chief Executive Officer

Agilent Technologies

Agilent Technologies Pipeline

DrugIndicationPhase
Infinity II LC SystemsDrug discovery and developmentCommercial
6500 Series LC-MS/MSClinical diagnosticsCommercial
SureSelect Target EnrichmentCancer genomicsCommercial
Bravo NGS WorkstationNGS sample preparationCommercial
Seahorse XF AnalyzersCell metabolism analysisCommercial
PARiS PlatformPathology AI solutionsCommercial